Max Healthcare Institute shares experienced a notable decline, dropping 2.62% to ₹1,095.30 on Friday, according to latest market data. The stock is a constituent of the Nifty 50 index, and the decline reflects broader market dynamics despite the company's strong financial performance. As per Moneycontrol reports, the stock's performance reflects investor sentiment, with the company maintaining its position as a prominent player in the healthcare sector.
Max Healthcare Institute demonstrated remarkable financial growth in FY2026, with consolidated revenue increasing by 19.13% to ₹8,373.45 crore from ₹7,028.46 crore in 2025. Net profit surged by 34.07% to ₹1,442.41 crore compared to ₹1,075.88 crore in the previous year. Earnings Per Share (EPS) demonstrated robust growth, rising from ₹11.07 in 2025 to ₹14.83 in 2026. The company's Return on Networth/Equity (ROE) stood at 13.42% in March 2026, indicating sound profitability metrics. Over a three-year period ending March 2026, the company's CAGR for sales was 35.47%, while its net profit CAGR was 14.33%. The company's market capitalisation stands at ₹1,08,166.31 crore as of the latest data, reflecting its position as one of India's leading healthcare providers.
For the quarter ending March 2026, consolidated revenue was ₹2,142.89 crore, representing an increase of 12.21% from ₹1,909.74 crore in the corresponding quarter of 2025. Net profit for the same period increased by 7.28% from ₹319.00 crore to ₹342.22 crore, while EPS improved from ₹3.28 to ₹3.52. The company maintained healthy operational margins with net profit margin at 17.22% and operating margin at 23.39% for the quarter. Revenue has been growing consistently over the last 2 quarters, with an average increase of 3.6% per quarter, while net profit has shown steady growth with an average increase of 12.1% per quarter over the same period.
Max Healthcare Institute's balance sheet for FY2026 shows total assets increasing to ₹17,230 crore from ₹15,214 crore in March 2025, reflecting robust business expansion. Cash flow from operating activities stood at ₹1,633 crore for the year ending March 2026, an increase from ₹1,459 crore in the previous year, highlighting healthy operational cash generation. The company's debt-to-equity ratio remained low at 0.27 as of March 2026, indicating strong financial health and efficient capital management. Return on Capital Employed (ROCE) as of July 30, 2026 stands at 74.89x, reflecting efficient capital utilization across the business. Total assets increased to ₹17,230 crore from ₹15,214 crore, with fixed assets growing to ₹10,095 crore from ₹8,922 crore in the previous year.
Max Healthcare Institute announced a final dividend of ₹2.00 per share (20%) for the financial year ending March 2026, with an effective date of July 3, 2026. This translates to a dividend yield of 0.18% and follows a dividend of ₹1.50 per share (15%) announced on May 20, 2025. The company also made disclosures under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on July 29, 2026, and issued a Business Responsibility and Sustainability Report for FY2025-26 on July 8, 2026. Mutual Funds have increased their holdings from 16.31% to 18.68% in the June 2026 quarter, while Foreign Institutions decreased their holdings from 45.39% to 41.78% during the same period.
